Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3

Blood

Volumn 99, Issue 10, 2002, Pages 3806-3812

  Ott, German ^a,b   Katzenberger, Tiemo ^a   Lohr, Andreas ^a   Kindelberger, Steffi ^a   Rüdiger, Thomas ^a   Wilhelm, Martin ^a   Kalla, Jörg ^a   Rosenwald, Andreas ^a   Müller, Justus G ^a   Michaela Ott, M ^a   Müller Hermelink, Hans Konrad ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CELL STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CLINICAL FEATURE; CYTOGENETICS; FOLLICULAR LYMPHOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037093035     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3806     Document Type: Article

References (44)

1. Follicular lymphoma
2. Updated Kiel classification for lymphomas
3. Follicular large-cell lymphoma: Intermediate or low grade?
4. What's the deal with follicular lymphomas?
5. Follicular large-cell lymphoma treated with intensive chemotherapy: An analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma: Groupe d'Etude des Lymphomes de I'Adulte
6. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry
7. Nonparametric estimation from incomplete observations
8. Regression models and life tables
9. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
10. Nodular histiocytic lymphoma: An aggressive nodular lymphoma with potential for prolonged disease-free survival
11. Nodular histiocytic lymphoma: Factors influencing prognosis and implications for aggressive chemotherapy
12. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas
13. Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma
14. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment
15. Multiple recurrent genomic defects in follicular lymphoma: A possible model for cancer
16. Bcl-2 protein expression in follicular lymphomas in absence of 14; 18 translocation
17. V(D)J recombinase-mediated transposition of the BCL2 gene to the IgH locus in follicular lymphoma
18. Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma
19. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
20. Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease
21. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
22. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
23. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
24. Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma
25. Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes
26. Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21)
27. Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma
28. Prognostic value of chromosomal abnormalities in follicular lymphoma
29. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)
30. High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma
31. Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma
32. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma: Kiel-Wien-Lymphoma Study Group
33. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma
34. Expression of the bcl-2 gene product in follicular lymphoma
35. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma
36. Follicular large cell lymphoma: Long-term follow-up of 62 patients treated between 1973-1981
37. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes: Non-Hodgkin's Lymphoma Classification Project
38. Frequent deletions of 6q23-24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization
39. Detection of the t(14; 18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation
40. Genomic aberrations and survival in chronic lymphocytic leukemia
41. The hallmarks of cancer